GPC1 and cancer: In 2015, Melo et al. reported that glyican-1 (GPC1), a cell surface proteoglycan, was specifically enriched in cancer cell-derived exosomes and could distinguish pancreatic cancer from non-cancer subjects with absolute specificity and sensitivity.